C07K 5/0819
With the first amino acid being acidic
Official title: {with the first amino acid being acidic}
C07K5/0819 (With the first amino acid being acidic) appears on 352 US grants and 348 published applications in this corpus.
Search patents in C07K- Granted patents
- 352
- Published applications
- 348
- Assignees
- 265
- Inventors
- 992
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 1 | 0 |
| 1978 | 4 | 0 |
| 1979 | 3 | 0 |
| 1980 | 3 | 0 |
| 1981 | 4 | 0 |
| 1982 | 3 | 0 |
| 1983 | 1 | 0 |
| 1984 | 3 | 0 |
| 1985 | 1 | 0 |
| 1986 | 4 | 0 |
| 1987 | 1 | 0 |
| 1988 | 4 | 0 |
| 1989 | 1 | 0 |
| 1990 | 4 | 0 |
| 1991 | 5 | 0 |
| 1992 | 8 | 0 |
| 1993 | 4 | 0 |
| 1994 | 5 | 0 |
| 1995 | 5 | 0 |
| 1996 | 5 | 0 |
| 1997 | 5 | 0 |
| 1998 | 14 | 0 |
| 1999 | 10 | 0 |
| 2000 | 16 | 0 |
| 2001 | 10 | 0 |
| 2002 | 11 | 6 |
| 2003 | 6 | 12 |
| 2004 | 5 | 18 |
| 2005 | 5 | 8 |
| 2006 | 11 | 16 |
| 2007 | 5 | 16 |
| 2008 | 5 | 12 |
| 2009 | 8 | 16 |
| 2010 | 9 | 19 |
| 2011 | 14 | 16 |
| 2012 | 11 | 20 |
| 2013 | 22 | 21 |
| 2014 | 11 | 14 |
| 2015 | 12 | 18 |
| 2016 | 13 | 10 |
| 2017 | 13 | 14 |
| 2018 | 6 | 14 |
| 2019 | 8 | 14 |
| 2020 | 9 | 16 |
| 2021 | 14 | 9 |
| 2022 | 6 | 14 |
| 2023 | 5 | 6 |
| 2024 | 4 | 17 |
| 2025 | 4 | 14 |
| 2026 | 8 | 8 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Peptide, cell growth promoter, protein production promoter, culture medium, cell growth method using peptide, and protein production method using peptide15 Sep 2026US 12,735,451 B2Maruhachi Muramatsu, Inc.
- Preparation method, intermediates, and use of cyclic peptide toxin alpha-amanitin and/or amaninamide1 Sep 2026US 12,723,060 B2Inner Mongolia Duhe Innovation R & D Tech Co., Ltd
- Labyrinthin-based peptides for cancer immunotherapies and uses thereof16 Jun 2026US 12,655,184 B2LabyRx Immunologic Therapeutics (USA) Limited
- Method for producing gamma-glutamyl-valyl-glycine and/or a salt thereof24 Mar 2026US 12,584,157 B2Ajinomoto Co., Inc.
- PSMA-targeting imaging agents10 Mar 2026US 12,569,577 B2The Cleveland Clinic Foundation
- Synthesized biologically active compounds and methods of making and using24 Sep 2026US 2026/0285903 A1Georgia State University Research Foundation, Inc.
- Production method for induced pluripotent stem cells27 Aug 2026US 2026/0250638 A1Sekisui Chemical Co., Ltd.
- Peptide inhibiting formation of snare complexes, and cosmetic composition containing same16 Jul 2026US 2026/0200973 A1Supadelixir Inc.
- Compounds, linker units comprising the same, and uses thereof in treating diseases18 Jun 2026US 2026/0167669 A1T-E Meds Inc.
- Compounds and methods for treating diseases caused by viruses and bacteria28 May 2026US 2026/0146062 A1The Trustees of Indiana University
Most cited
By later US patents
- Tetrapyrrole therapeutic agents113US 4,675,338 ANippon Petrochemicals Company, Limited · 1987
- Synthetic peptide inhibitors of HIV transmission102US 5,464,933 ADuke University · 1995
- CS-1 peptidomimetics, compositions and methods of using the same95US 5,770,573 ACytel Corporation · 1998
- Chelating compounds for metal-radionuclide labeled proteins89US 4,965,392 ANeoRx Corporation · 1990
- Cationic lipids85US 8,759,104 B2The University Court of the University of Edinburgh · 2014